Partnership with leading non-profit to deliver targeted messages direct to clinicians within their EHR to help reduce patients’ out-of-pocket costs for medication
CHICAGO–(BUSINESS WIRE)–#healthIT–Allscripts Healthcare Solutions (NASDAQ: MDRX) and its payer and life science business unit, Veradigm™, today announced a new partnership with the Patient Access Network (PAN) Foundation, an independent, national 501(c)(3) organization dedicated to helping federally and commercially insured people living with life-threatening, chronic and rare diseases with the out-of-pocket costs for their prescribed medications. Veradigm will leverage its market-leading electronic health record (EHR) messaging capabilities at no cost to the PAN Foundation, delivering information to users of its Veradigm ePrescribe and Practice Fusion EHR platforms to generate awareness and support utilization of the foundation’s programs among tens of thousands of clinicians.
The PAN Foundation’s mission is to help underinsured people with life-threatening, chronic and rare diseases get the medications and treatments they need by assisting with their out-of-pocket costs and advocating for improved access and affordability. To that end, the organization has provided nearly one million underinsured patients with $3 billion in financial assistance since 2004.
Veradigm’s provider messaging solutions provide a unique, proven approach to effectively generate awareness, support education, and relay critical information directly to clinicians through their Veradigm EHR platforms, within their day-to-day workflow.
“We are proud to provide the PAN Foundation with an effective method to communicate opportunities from the Foundation for clinicians to help their patients reduce the cost of their medication,” says Veradigm VP and General Manager Don Dorfman. “Through our Veradigm RxTruePrice™ solution, Veradigm is already a front-line leader in the fight to make medication more affordable for patients by delivering patient-specific pricing directly to the point of care. Now in partnering with the PAN Foundation, we are empowering providers and patients with access to potential avenues to reduce their cost of care and improve medication adherence and ultimately outcomes.”
Veradigm partners with healthcare stakeholders like non-profits, biopharma companies, payers, and others to deliver targeted messages specific to provider specialty across appropriate touchpoints throughout the user’s EHR workflow.
“In working with Veradigm to enhance our ability to communicate with clinicians at the point of care, the PAN Foundation reinforces our commitment to connecting seriously ill and underinsured patients with the financial assistance they need to start and stay on treatment, ,” says PAN Foundation President and CEO Dan Klein. “By coming together with partners like Veradigm, we can expand access to and awareness of our patient assistance programs to reduce the out-of-pocket costs of treatment and improve the lives of patients across the country.“
Learn more about the PAN Foundation here.
Learn more about Veradigm solutions for provider messaging here.
About Veradigm™
Veradigm is an integrated data systems and services company that combines data-driven clinical insights with actionable tools to help healthcare stakeholders improve the quality, efficiency, and value of healthcare delivery— including biopharma, health plans, healthcare providers, health technology partners, and most importantly, the patients they serve. We are dedicated to simplifying the complicated healthcare system with next-generation healthcare solutions. This is how we are transforming health, insightfully. To learn more, visit www.veradigmhealth.com.
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
Contacts
Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com
Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com
FDA has Accepted for Review the Treosulfan NDAManagement to host conference call at 8:00 AM…
CHICAGO, June 25, 2024 /PRNewswire/ -- A new Journal of Alzheimer's Disease article unveils an…
CHICAGO, June 25, 2024 /PRNewswire/ -- Following a triumphant return as a weekly broadcast, The…
STOCKHOLM, June 25, 2024 /PRNewswire/ -- Neonode Inc. (NASDAQ: NEON), announced today that its 2024…
NEW YORK, June 25, 2024 /PRNewswire/ -- Adonis, a leading healthcare financial technology platform based…
COLUMBIA, Mo., June 25, 2024 /PRNewswire/ -- OBERD, the industry-leading patient-reported outcomes (PRO) vendor, has…